NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 221 filers reported holding NATERA INC in Q2 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $209,000 | -20.8% | 2,240 | -5.4% | 0.00% | 0.0% |
| Q3 2021 | $264,000 | -84.8% | 2,367 | -86.2% | 0.00% | -87.5% |
| Q1 2021 | $1,740,000 | -49.2% | 17,139 | -50.2% | 0.01% | -46.7% |
| Q4 2020 | $3,427,000 | +32.2% | 34,431 | -4.1% | 0.02% | +25.0% |
| Q3 2020 | $2,593,000 | +109.6% | 35,896 | +44.6% | 0.01% | +100.0% |
| Q2 2020 | $1,237,000 | +92.1% | 24,816 | +15.0% | 0.01% | +50.0% |
| Q1 2020 | $644,000 | -0.3% | 21,576 | +12.6% | 0.00% | +33.3% |
| Q4 2019 | $646,000 | +2.5% | 19,163 | -0.2% | 0.00% | 0.0% |
| Q3 2019 | $630,000 | +126.6% | 19,198 | +90.7% | 0.00% | +200.0% |
| Q2 2019 | $278,000 | -65.9% | 10,068 | -76.7% | 0.00% | -80.0% |
| Q2 2018 | $815,000 | +135.5% | 43,290 | +61.3% | 0.01% | +150.0% |
| Q3 2017 | $346,000 | +129.1% | 26,830 | +93.2% | 0.00% | +100.0% |
| Q2 2017 | $151,000 | – | 13,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |